The exact etiology of delayed cerebral vasospasm following cerebral hemorrhage is not clear, but a family of compounds termed 'bilirubin oxidation end products (BOXes)' derived from heme has been implicated. As proper regulation of vascular smooth muscle tone involves large-conductance Ca 2 + -and voltage-dependent Slo1 K + (BK, maxiK, K Ca 1.1) channels, we examined whether BOXes altered functional properties of the channel. Electrophysiological measurements of Slo1 channels heterologously expressed in a human cell line and of native mouse BK channels in isolated cerebral myocytes showed that BOXes markedly diminished open probability. Biophysically, BOXes specifically stabilized the conformations of the channel with its ion conduction gate closed. The results of chemical amino-acid modifications and molecular mutagenesis together suggest that two specific lysine residues in the structural element linking the transmembrane ion-permeation domain to the carboxyl cytosolic domain of the Slo1 channel are critical in determining the sensitivity of the channel to BOXes. Inhibition of Slo1 BK channels by BOXes may contribute to the development of delayed cerebral vasospasm following brain hemorrhage.
Introduction
Large-conductance Ca 2 + -and voltage-dependent Slo1 K + (BK, maxi-K, K Ca 1.1) channels open in response to an increase in intracellular Ca 2 + concentration and/or depolarization, generally providing a negative feedback influence on cellular excitability (Salkoff et al, 2006) . Physiologic roles of Slo1 BK channels are well documented in many phenomena, including regulation of smooth muscle tone, determination of action potential duration, action potential frequency adaptation, neurotransmitter release, and neurovascular coupling (reviewed in Salkoff et al (2006) ). Mice with the gene for the Slo1 channel pore-forming subunit (Kcnma1) or the predominantly vascular auxiliary subunit b1 (Kcnmb1) disrupted exhibit various smooth muscle-related phenotypes, including hypertension (Brenner et al, 2000; Sausbier et al, 2005) , erectile dysfunction (Werner et al, 2005) , and urinary incontinence (Meredith et al, 2004; Werner et al, 2005) along with other neuronal phenotypes (Salkoff et al, 2006) . Although compensatory responses for the gene disruption may occur (Sprossmann et al, 2009) , the phenotypes observed in the genetically modified mice are generally consistent with the concept that activation of Slo1 BK channels promotes vascular relaxation and inhibition of the channels facilitates vascular constriction (Nelson et al, 1995) .
Some human diseases may be associated with the dysregulation of Slo1 BK channels. For instance, a mutation in one of the putative Ca 2 + -sensor regions of the Slo1 channel is linked to epilepsy and paroxysmal movement disorder (Du et al, 2005) . A form of hypertension has been reported to involve downregulation of the vascular Slo1 BK channel complex (Amberg and Santana, 2003) , and a gain-offunction mutation in the auxiliary subunit gene b1 may offer protection against diastolic hypertension (Fernández-Fernández et al, 2004) . Furthermore, pharmacological openers of Slo1 BK channels have been suggested to have a neuroprotective role following stroke (Gribkoff et al, 2001) .
Subarachnoid hemorrhage (SAH) is a serious condition that claims many lives, and even those patients who survive the initial incidence often face delayed high mortality and exhibit delayed neurologic deterioration (Macdonald et al, 2007) . Subarachnoid hemorrhage is often followed by delayed cerebral vasospasm, long-lasting narrowing of cerebral blood vessels, typically occurring 1 week after the initial hemorrhage (Macdonald et al, 2007) . Although a definitive single etiology has not been established, heme and heme breakdown products released from hematomas may have critical roles in the vasospasm (Macdonald and Weir, 1991) . In particular, a class of heme breakdown products known as bilirubin oxidation end products (BOXes; Figure 1A ), small pyrroline derivatives, has been implicated (Clark et al, 2002; Clark and Sharp, 2006; Clark et al, 2008; Kranc et al, 2000; Pyne-Geithman et al, 2005) . Bilirubin oxidation end products are present in cerebral spinal fluids (CSFs) of cerebral hemorrhage patients with vasospasm at concentrations of up to 1 mmol/L in the extracellular compartment (Pyne-Geithman et al, 2005) and potentiate contraction of isolated porcine carotid arteries (Clark et al, 2002; Kranc et al, 2000; Pyne-Geithman et al, 2008) . Therefore, the evidence supports the idea that BOXes are important in the development of delayed cerebral vasospasm; however, the effectors or molecular targets of BOXes are only beginning to be revealed. Thus far, protein kinase C and the small GTPase Rho A have been suggested as direct or (bottom) . Currents were elicited by pulses to 160 mV and then to À80 mV from the holding voltage of 0 mV in the inside-out configuration. At 160 mV, G/G max is B0.5. BOXes (10 mmol/L assuming the average molecular weight of 200 g/ mol) were applied to the cytoplasmic side for 400 seconds and then washed out. Peak outward current amplitudes at different times were scaled to the average peak outward current size before the application of BOXes and plotted as a function of time.
The smooth curve represents an exponential fit to the data with a time constant of 79.5 ± 2.3 seconds and the fractional steadystate level of 0.27±0.004. (D) Mean time courses of the fractional current inhibition by four different concentrations of BOXes (0.1, 1, 10, and 100 mmol/L). The currents were elicited as described in panel C. The shaded areas represent s.e.m. n = 3 to 8. (E) Sunlight-exposed BOXes are not effective in inhibiting the Slo1 channel current. Mean scaled current size in the presence of sunlight-exposed BOXes (10 mmol/L). Currents were elicited as described in panel C. The shaded area represents s.e.m. n = 4. The sample was exposed to sunlight for > 6 hours. (F) Application of BOXes (10 mmol/L) to the extracellular side is also effective. The currents in the outside-out configuration were elicited by pulses to 100 mV. n = 3. The intracellular solution contained no Ca 2 + . BOXes, bilirubin oxidation end products.
indirect effectors of BOXes . It is not known whether BOXes affect other cell constituents. The importance of Slo1 BK channels in the regulation of vascular smooth muscle tone (Nelson et al, 1995) and the vasoconstrictive ability of BOXes (Clark et al, 2002; Kranc et al, 2000; Pyne-Geithman et al, 2008) together raise the possibility that BOXes may regulate functional properties of Slo1 BK channels. If BOXes inhibit the activity of Slo1 BK channels in vascular smooth muscle cells, the inhibition could promote vascular constriction. In this study, we therefore examined whether BOXes alter functional properties of Slo1 BK channels using electrophysiological and molecular biological methods.
Materials and methods
Human large-conductance Ca 2 + -and voltage-gated Slo1 K + channels (U11058/AAB65837) were heterologously expressed in human embryonic kidney (HEK) cells using FuGene 6 (Roche, Indianapolis, IN, USA) (Horrigan et al, 2005) . In some experiments, Slo1 was cotransfected with mouse b1 (AAH13338) or human b1 (AAS20193) (1:1 weight ratio). Other constructs used are noted in the figure legends. Mutations were introduced to Slo1 using a standard PCRbased mutagenesis method (Agilent, Santa Clara, CA, USA) and the sequences were verified (University of Pennsylvania DNA Sequencing Facility, Philadelphia, PA, USA).
Basilar arteries and their main branches were collected from B2-month-old C57BL/6 mice using the protocol of Jaggar (2001) , except that dithiothreitol replaced dithioerythritol. The animals were killed according to a protocol approved by the University of Pennsylvania Animal Care and Use Committee. Smooth muscle cells were identified by their elongated appearance.
Electrophysiological experiments were performed and the results were analyzed as described previously (Horrigan et al, 2005) . The inside-out configuration of the patchclamp method was used primarily to record ionic currents at room temperature using an Axopatch 200A or 200B amplifier (Molecular Devices, Sunnyvale, CA, USA). The output of the amplifier was digitized (ITC16, HEKA, Bellmore, NY, USA) and stored for later analysis. For macroscopic current measurements, the recording pipettes made of borosilicate glass (Warner, Hamden, CT, USA) had a typical resistance of 0.8 to 1 Mohms when filled with the solution described below and X50% of the initial pipette resistance was electronically compensated. Native BK channel currents were recorded with the extracellular solution containing (in mmol/L): 134 NaCl, 6 KCl, 1 MgCl 2 , 2 CaCl 2 , 10 glucose, 10 HEPES, pH 7.4 with NMG (Nmethyl-D-glucamine). For measurements of heterologously expressed channels, the extracellular solution contained (in mmol/L): 140 KCl, 2 MgCl 2 , 10 HEPES, pH 7.2 (NMG). The 'zero' Ca 2 + intracellular solution contained (in mmol/ L): 140 KCl, 11 EGTA, 10 HEPES, pH 7.2 (NMG). The solutions with [Ca 2 + ] i X100 mmol/L did not contain any exogenous chelator. Macroscopic capacitative and leak currents were subtracted using a P/6 protocol. Bilirubin oxidation end products were perfused to the recording chamber (B180 mL in volume) only after currents were stable.
The electrophysiological results were analyzed using custom routines implemented in IgorPro (WaveMetrics, Lake Oswego, OR, USA). To generate macroscopic conductance-voltage (GV) curves, tail currents, excluding the initial B180 microseconds to avoid capacitative transients, at À80 mV following prepulses to different voltages were fitted with a single exponential function, and the extrapolated amplitudes at t = 0 second were in turn fitted as a function of voltage with a simple Boltzmann equation as a data descriptor. Each GV curve was scaled using the maximal conductance estimated from the extrapolated tail current amplitudes following prepulses to very depolarized voltages (G max ; typically at X230 mV), so that each data set was described by the equation:
where Q app (in e 0 ) describes the steepness of the curve, V 0.5 (half-activation voltage) represents the voltage at which the scaled macroscopic conductance is 0.5, V is the voltage, F Faraday constant, R gas constant, and T temperature. Macroscopic current kinetics was fitted with a single exponential, excluding the initial B180 microseconds at p100 mV and 250 microseconds at X140 mV. The voltage dependence of the time constant was in turn fitted with the equation t(V) = t 0 exp(qFV/RT), where t(V) is the time constant at voltage V, t 0 the time constant value at 0 mV, q (in e 0 ) the partial charge value describing the steepness of the voltage dependence, F Faraday constant, V voltage, R gas constant, and T the temperature.
Single-channel open probability at negative voltages was estimated from all-point amplitude histograms using the half-amplitude criterion and corrected for the number of channels present in each patch. The number of channels was determined from the peak macroscopic current size recorded in the same patch at X160 mV before application of BOXes. The single-channel current-voltage curve (i(V)) and the voltage dependence of absolute open probability (P o (V)) of the wild-type channel measured in our previous study (Horrigan et al, 2005) determined the number of channels present using the equation
where I(V) is the peak macroscopic current size at voltage V and N the number of channels.
The statistical results are presented as mean ± s.e.m. (n). Statistical evaluations, typically paired Student's t-test, were performed using IgorPro or DataDesk (DataDescription, Ithaca, NY, USA). Multiple comparisons of means were performed by ANOVA (analysis of variance), followed by the Bonferroni test with DataDesk. The equation fit parameter values are presented as mean ± 95% confidence interval as implemented in IgorPro.
Bilirubin oxidation end products were synthesized and purified according to the protocol of Kranc et al (2000) . Three members are present in the samples of BOXes used, namely BOX A, BOX B, and MVM (4-methyl-3-vinylmaleimide) (Kranc et al, 2000) . Separation of BOXes to the individual components is difficult and drastically decreases the yield to < 5% (Kranc et al, 2000) , and the mixture containing all three components was used in the experiments presented herein because this is the ratio (2:2:1) found in CSF (BOX A, BOX B, and MVM, respectively). However, the preparations of BOXes were essentially free of bilirubin and other bilirubin derivatives. Bilirubin oxidation end products were applied with minimal illumination, typically to the cytoplasmic side and washed out. The effects of BOXes were slow to reverse (see below) and most of the results shown are comparisons of those obtained before and after treatment with BOXes followed by a washout. When the kinetics of the inhibitory effect of BOXes was examined, repeated pulses to a single voltage, at which the open probability was B0.5, were applied.
Simulations using the Horrigan and Aldrich (HA) model of gating of the Slo1 channel were performed as described previously (Horrigan et al, 2005) . To simulate the results in the absence of Ca 2 + , the kinetic model ( Figure 5A , bottom; Horrigan et al, 1999 ) was used to generate ionic currents with the parameter values shown in Table 1 . The simulated ionic currents were then analyzed as described above to generate GV curves and the voltage dependence of the macroscopic time constant. The GV curves at different concentrations of Ca 2 + were analytically simulated ( Figure  5A , top) using a custom routine implemented in IgorPro (Horrigan et al, 2005) .
Chloramine-T, DEPC (diethyl pyrocarbonate), PGO (phenylglyoxal), dimethyl adipimidate (DMA), and iodoacetamide were obtained from Sigma (St Louis, MO, USA). Both MTSEA (2-aminoethyl methanethiosulfonate) and MTSET (2-(trimethylammonium) ethyl methanethiosulfonate) were acquired from Biotium (Hayward, CA, USA). The reagents were prepared immediately before use and applied to the intracellular side. The reagents were washed out of the chamber and the sensitivity to BOXes was examined.
Results
Application of BOXes ( Figure 1A ; 10 mmol/L) to the cytoplasmic side of a membrane patch excised from a mouse cerebral artery myocyte markedly decreased the frequency of Slo1 BK channel openings ( Figure  1B) . To elucidate the biophysical and molecular mechanisms of the inhibitory action of BOXes in detail, we heterologously expressed human Slo1 channels in HEK cells. The opening and the closing of the ion conduction gate of the Slo1 channel are allosterically controlled by its transmembrane voltage and cytoplasmic Ca 2 + sensors ( Figure 5A, top) , and a full description of the voltage-and Ca 2 +dependent gating of the channel requires a large number of conformational states (Horrigan and Aldrich, 2002) . To simplify interpretations of the electrophysiological results, our initial experiments were performed in the virtual absence of Ca 2 + , such that the channel opening is allosterically controlled only by the voltage sensors (Horrigan et al, 1999 ; Figure 5A ). As found with the native myocyte BK channels ( Figure 1B ), application of BOXes (10 mmol/L) to the cytoplasmic side of an excised cell-free membrane patch containing Slo1 channels progressively decreased the current elicited by depolarization roughly following an exponential time course with a time constant value of B80 seconds ( Figure  1C ). Extensive wash, up to B10 minutes, did not fully reverse the inhibition ( Figure 1C ), indicating a stable interaction between BOXes and the channel protein. Similar measurements in multiple experiments showed that the kinetics of inhibition became faster with greater concentrations of BOXes ( Figure  1D ). For X10 mmol/L, the steady-state fractional inhibitions observed within a typical lifetime of a patch (B15 minutes) were similar. Lower concentrations of BOXes (0.1 and 1 mmol/L) appeared less effective ( Figure 1D ), but it was not clear whether the inhibition reached steady state within the limited measurement duration. The inhibition time courses with BOXes were indistinguishable whether the holding voltage was 0 or À100 mV (data not shown).
A previous study has identified that one of the notable characteristics of BOXes is that their vasoconstrictive ability is diminished by exposure to sunlight (Kranc et al, 2000) . Consistent with this report, application of sunlight-exposed BOXes was much less effective in altering the current size ( Figure 1E ).
Application of BOXes to the extracellular side was also effective ( Figure 1F ), but the inhibition kinetics was often slower than that observed with application of BOXes to the intracellular side. The faster action of BOXes applied to the cytoplasmic side may signify that the sites on the channel required for the interaction with BOXes are more readily accessed from the intracellular side. The results presented in the remainder of this article were obtained using application of BOXes to the intracellular side using cell-free inside-out membrane patches. Bilirubin oxidation end products were typically applied at 10 mmol/L, because the inhibition kinetics with this concentration was rapid enough to obtain sufficient results using the patch-clamp method.
Single-channel current-voltage curves before and after treatment with BOXes (10 mmol/L for 10 minutes) were indistinguishable, showing that BOXes had no effect on the open-channel ion-conduction properties ( Supplementary Figure 1) . In contrast, voltage-dependent steady-state activation of the Slo1 channel was markedly altered by BOXes (Figure 2A ). The Slo1 currents were inhibited more noticeably at less depolarized voltages (e.g., 120 versus 200 mV in Figure 2B ). The inhibition was accompanied by a B35 mV shift in half-activation voltage (V 0.5 ) of macroscopic conductance (GV) to the positive direction ( Figures 2C and 2D ; 160 ± 4 mV versus 194±3 mV; P < 0.0001). The slope of the GV curve was also shallower; the apparent charge movement estimated from Boltzmann fits decreased by B15% from B1.10±0.04 to 0.96±0.04 e 0 (P < 0.005; Figure 2D ). Treatment with BOXes also altered the kinetics of the channel. Bilirubin oxidation end products noticeably slowed the activation kinetics at positive voltages at which the opening transitions dominate and open probability (P o ) is high (Figures 2E and 2F ). For example, at 230 mV, the activation time constant increased by 3.60 ± 0.38-fold ( Figure 2F ). In addition, after treatment with BOXes, the activation time constant was less voltage dependent, corresponding to a B30% decrease in the partial charge movement ( Figure 2F ). In contrast, at negative voltages at which the closing transitions dominate and P o is low (p0 mV), treatment with BOXes failed to affect the deactivation kinetics of the channel (Figures 2E  and 2F) .
At extreme negative voltages (pÀ100 mV), the primary voltage sensors of the Slo1 channel largely assume the resting conformation ( Figure 5A ) (Horrigan et al, 1999) . As voltage-sensor activation is not strictly required for the ion conduction gate of Slo1 to open, single-channel currents can be observed at such extreme negative voltages, although infrequently ( Figures 3A and 5A) (Horrigan et al, 1999) . Treatment with BOXes decreased P o at such negative voltages ( Figures 3A and 3B) ; at À150 mV, P o decreased to 10.6% ± 5.0% of the control level. In contrast with the marked decreases in P o , the mean open durations determined by the closing transition(s) ( Figure 5A , bottom) remained unaltered by BOXes at these negative voltages ( Figure 3C) .
The results presented thus far show that treatment with BOXes leads to marked alterations in the functional properties of the Slo1 BK channels in the absence of Ca 2 + , reflecting the reciprocal and allosteric interactions between the gate and voltage sensors of the channel ( Figure 5A ). As physiologic activation of the Slo1 BK channel often involves intracellular Ca 2 + (Nelson et al, 1995) , we examined whether BOXes altered the Ca 2 + sensitivity of the channel. After treatment with BOXes (10 mmol/L), Slo1 currents remained dependent on [Ca 2 + ] i , increasing in size with higher concentrations (Figures 4A and  4B) . At a given Ca 2 + concentration, BOXes shifted the voltage dependence of activation as measured by V 0.5 to the positive direction by 30 to 50 mV ( Figure  4C ). However, when normalized to the respective V 0.5 values in the absence of Ca 2 + (Figure 4D ), the control channels and the channels treated with BOXes had Figure 2 BOXes alter gating properties of Slo1 in the absence of Ca 2 + . (A) Representative Slo1 currents recorded at different voltages before and after treatment with BOXes. The channels were treated with BOXes (10 mmol/L) for 6 minutes and washed. (B) Peak IV curves before and after treatment with BOXes. (C) Representative normalized GV curves estimated from tail currents before and after treatment with BOXes. The results were obtained from the same patch as shown in panel A. (D) Mean GV parameters, V 0.5 (top) and Q app (bottom), before and after treatment with BOXes; n = 6. (E) Scaled representative Slo1 currents recorded at different voltages before (thin sweeps) and after (thick sweeps) treatment with BOXes (10 mmol/L for 6 minutes) to illustrate the differential effects on deactivation and activation. (F) Voltage dependence of macroscopic Slo1 current kinetics before (open circles) and after (filled circles) treatment with BOXes. The time constant values at X170 mV were fitted with an exponential function. The time constant at 0 mV and the partial charge in the control group were 53 ± 21 milliseconds and 0.3±0.05 e 0 , respectively. The respective values after treatment with BOXes were 63 ± 0.2 milliseconds and 0.2 ± 0.0001 e 0 . n = 7. BOXes, bilirubin oxidation end products. similar Ca 2 + dependence of activation. For example, in both groups, 1 mmol/L Ca 2 + caused a À70 mV shift of V 0.5 , and 200 mmol/L Ca 2 + , a near saturating concentration for the high-affinity Ca 2 + sensors of the Slo1 channel (Yang et al, 2008) , caused a À200 mV shift in V 0.5 ( Figure 4D ).
Steady-state activation properties of the Slo1 BK channel are described by the model of Horrigan and Aldrich (2002) (HA model), and the kinetic characteristics in the absence of Ca 2 + are well approximated by a subset of the HA model (HCA model; Horrigan et al, 1999) as depicted in Figure 5A . To gain biophysical insight, the HA model was used to simulate the action of BOXes on the Slo1 channel gating by varying the model parameter values in the following manner. Without Ca 2 + , at extreme negative voltages at which voltage-sensor activation is negligible, P o is largely determined by the rate constants d 0 and g 0 (Figure 5A, bottom) . The ratio d 0 /g 0 defines the equilibrium constant L in the HA model ( Figure 5A , top). The closing rate constant g 0 is the primary determinant of the mean open duration and of the macroscopic deactivation kinetics at negative voltages. As treatment with BOXes decreased P o by B10-fold but failed to alter the mean open duration or the deactivation kinetics at negative voltages, it is reasoned that BOXes decrease the equilibrium constant L 0 defined as d 0 /g 0 at 0 mV by B10-fold by decreasing the opening rate constant d 0 without altering the closing rate constant g 0 . The 10-fold decrease in d 0 necessitates the same fractional changes in d 1À4 to maintain microscopic reversibility ( Figure 5A, bottom) , including the opening rate constant d 4 , which dominates the activation kinetics at positive voltages. Experimentally, however, only an approximately three-fold increase in the activation kinetics at positive voltages was observed after treatment with BOXes ( Figure 2) ; the decrease in d 4 alone was constrained accordingly to simulate the kinetic changes at positive voltages. The changes in the parameter values are summarized in Table 1 . With these changes incorporated, the model predicts the kinetic and steady-state properties that are in general agreement with the experimental results ( Figures 5B-5D ).
To explore which amino-acid residues of the Slo1 protein are required for the inhibitory effect of BOXes, we pretreated the channels with different amino-acid-modifying reagents and then, after washout, assessed the sensitivity of the modifier-treated channels to BOXes. Pretreatment with the methionine-preferring modifier chloramine-T, the imidazole modifier DEPC, the arginine modifier PGO, the cysteine modifiers iodoacetamide, MTSEA, and MTSET failed to alter the sensitivity of the channel to BOXes (data not shown). In contrast, pretreatment with the lysine modifier DMA (Duszyk et al, 1998) noticeably decreased the sensitivity to BOXes (Figures 6A-6D ). The DMA pretreatment itself often decreased currents; however, the DMA-treated channels were clearly less sensitive to BOXes (Figures 6A  versus 6B ). Bilirubin oxidation end products (10 mmol/L for 400 seconds) decreased the current size only by 25% in DMA-treated channels compared with the B75% reduction observed in nontreated channels ( Figures 6B and 6D) .
The ability of the lysine-modifying agent DMA to antagonize the inhibitory effect of BOXes suggests an involvement of Lys residues. Each Slo1 subunit (U11058/AAB65837) possesses 59 Lys residues and the majority of them are located in the large cytoplasmic C-terminal area. Of the numerous Lys residues, we focused on those in the sequence 329 RKK 331 in the linker segment between the transmembrane segment S6 and the cytoplasmic RCK1 domain ( Figure 6E ). This sequence has been implicated in the direct action of phosphatidylinositol 4,5-bisphosphate (PIP 2 ); the triple mutation R329A:K330A:K331A (referred to as the RKK mutation hereafter) has been reported to diminish the stimulatory effect of PIP 2 by 50% (Vaithianathan et al, 2008) . Prompted by the purported importance of the 329 RKK 331 sequence, we tested whether the sensitivity of the channel to BOXes was also altered by the mutation. Indeed, the RKK mutation significantly diminished the sensitivity of the channel to (HCA model; bottom) . The ion conduction gate of the tetrameric Slo1 channel can be closed (C) or open (O) and the equilibrium is described by the equilibrium constant L. One channel contains four voltage sensor domains and each voltage sensor can be at rest (R) at negative voltages or activated (A) at depolarized voltages. The voltage-dependent equilibrium is described by the equilibrium constant J. For simplicity, each subunit is assumed to have a single Ca 2 + -sensor domain, which can be unoccupied (X) or occupied with a Ca 2 + ion (X Ca 2 + ). The equilibrium is described by the equilibrium constant K. D, C, and E describe the allosteric interactions among the gate, voltage sensors, and Ca 2 + sensor domains, respectively. For each voltage sensor activated, the equilibrium constant L increases by D-fold (LD), thus leading to an increase in open probability. When all four voltage sensors are activated, the effective equilibrium constant is LD 4 . Similarly, activation of one Ca 2 + -sensor domain increases L by C-fold (LC). When all four Ca 2 + sensors are occupied, L increases by C 4 -fold (LC 4 ). Activation of all four voltage-sensor domains and of all four Ca 2 + -sensor domains together increases L by D 4 C 4 -fold (D 4 C 4 ). The bottom panel shows the gating model in the absence of Ca 2 + using rate constants. C 0 , C 1 , C 2 , C 3 , and C 4 refer to the closed states with 0, 1, 2, 3, and 4 voltage sensors activated, respectively. -0.17 À0.17 0 L 0 = d 0 (0)/g 0 (0) 5 Â 10 À5 5.3 Â 10 À6 ± 2.5 Â 10 À6 À90 ± 5 D 9.8 9. Horrigan et al (2005) , except that the constant D was lowered to 9.8 to better fit the data set in this study. The errors associated with L 0 and d 0À3 were taken from the P o measurements at À150 mV (see Figure 3 ) and that with d 4 was estimated from the activation time constant at 230 mV (see Figure 2 ).
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BOXes (Figures 6C and 6D ). After treatment with BOXes (10 mmol/L), B60% of the current remained in the RKK mutant compared with B30% remaining in the wild-type nontreated channel (Pp0.0017). The fractional currents remaining in the RKK mutant channel and the DMA-treated wild-type channel were indistinguishable (P = 0.086). The RKK mutant channel was also largely insensitive to treatment with DMA (data not shown).
The transmembrane segments and the cytoplasmic RCK1 domains of the Slo1 channel together coordinate Mg 2 + ions, which also promote the opening of the channel (Yang et al, 2008) . As the sequence 329 RKK 331 is located in the S6-RCK1 linker segment ( Figure 6E ), we examined whether treatment with BOXes altered the Mg 2 + sensitivity of the channel. Intracellular Mg 2 + (10 mmol/L) produced a B100 mV shift in V 0.5 to the negative direction in channels treated with BOXes ( Supplementary Figure 3) , which was indistinguishable from that in the control group.
Native vascular BK channel complexes include both the pore-forming Slo1 and auxiliary b1 subunits (Salkoff et al, 2006) . Consistent with the observation that BOXes inhibited native myocyte BK channels ( Figure 1B) , BOXes remained effective when Slo1 and b1 were heterologously coexpressed together ( Supplementary Figure 3) . In addition to Slo1 BK channels, vascular smooth muscle cells contain other K + channels, including Kv1.5 (Brevnova et al, 2004) . Bilirubin oxidation end products (10 mmol/L) did not alter currents through human Kv1.5 channels expressed in HEK cells ( Supplementary Figure 4 ).
Discussion
Bilirubin oxidation end products, heme breakdown products, are found in the CSF of SAH patients and have been implicated in the development of delayed cerebral vasospasm following SAH (Clark and Sharp, 2006; Clark et al, 2008; Kranc et al, 2000) . Although the molecular and cellular targets of BOXes are yet to be fully revealed, a recent study has shown that BOXes exert their action in part by regulating protein kinase C and GTPase Rho A . Our results here show that BOXes profoundly inhibit the Slo1 BK channel activity in a lysinedependent manner and suggest that the inhibitory effect of BOXes on the channel could contribute to the vasoconstrictive effect of BOXes.
Gating of the Slo1 channel involves reciprocal and allosteric interactions among the ion conduction gate of the channel, transmembrane voltage sensors, and cytoplasmic ligand-binding domains The patch was treated with freshly prepared DMA (10 mmol/L) in the recording solution for 10 minutes and washed for 10 minutes. (C) Sample current sweeps and a representative inhibition time course in the R329A:K330A:K330A channel ('RKK mutant') at 70 mV. The voltage dependence of the RKK mutant is shifted to the negative direction by B100 mV and G/G max is B0.5 at 70 mV. In panels A, B, and C, representative currents before and after treatment with BOXes are shown (top). (D) Fractional currents remaining in the wild-type channel, the wild-type channel treated with DMA and the RKK mutant after treatment with BOXes. The results of the DMA-treated and RKK mutant groups are significantly different from those in the control wild-type group (Pp0.0017, Bonferroni, n = 8 to 10). (E) Structural organization of a Slo1 subunit (left) and a cartoon representation of a tetrameric Slo1 channel viewed from the cytoplasmic side based loosely on the electron cryomicroscopy structure by Wang and Sigworth (2009) . BOXes, bilirubin oxidation end products; DMA, dimethyl adipimidate. (Horrigan et al, 1999; Horrigan and Aldrich, 2002) . After treatment with BOXes, the voltage dependence of activation of the channel is shallower and shifted to the positive direction, and the activation kinetics is also slower. These changes in gating can be readily accounted for by postulating that BOXes specifically slow the opening process of the ion conduction gate of the channel. A 70% to 90% decrease in each of the four opening rate constants (d 0À4 ) in the HA model of Slo1 gating provides a good approximation of the channel's gating after exposure to BOXes.
The inhibitory effect of BOXes is somewhat reminiscent of that of heme, which also alters the Slo1 channel activity (Tang et al, 2003) . Heme and its oxidized form hemin inhibit the channel at positive voltages in part by shifting the voltage dependence of activation to the positive direction (Tang et al, 2003) . In addition, the activation kinetics is noticeably slower in the presence of heme/hemin (Horrigan et al, 2005) . Despite the superficial resemblances, the underlying mechanisms of BOXes and hemin are markedly different. Bilirubin oxidation end products decrease the opening rate constant of the channel's gate (d 0 ) as shown in this study, whereas hemin increases the same rate constant (d 0 ) and weakens the allosteric coupling between the voltage sensors and the gate (D) (Horrigan et al, 2005 ) (see Figure 5A ). The differential effects of hemin and BOXes are particularly evident at negative voltages at which the primary voltage sensors of the channel are at rest; hemin increases but BOXes decrease P o , suggesting that hemin and BOXes could have opposing physiologic effects.
The different biophysical mechanisms of the actions of hemin and BOXes on the Slo1 channel are reflected in the distinct amino-acid residues of Slo1 important for the actions of these related molecules. A short sequence containing two Cys and a His residue located in the cytoplasmic linker segment between the RCK1 and RCK2 domains of the Slo1 channel has an important role in the sensitivity of the channel to hemin (Jaggar et al, 2005; Tang et al, 2003) . In contrast, the full sensitivity of the channel to BOXes requires the sequence 329 RKK 331 located downstream of the S6 transmembrane segment in the primary sequence.
The sequence 329 RKK 331 is also important in the direct action of the membrane-bound signaling molecule PIP 2 on the channel; contemporaneous mutation of the three residues to alanine has been reported to diminish the effect of PIP 2 by 50% (Vaithianathan et al, 2008) . Given the putative location of the sequence 329 RKK 331 downstream of the S6 segment, it may be speculated that BOXes position themselves between the transmembrane helices and the cytoplasmic RCK1 domain, and stabilize the closed conformation of the ion conduction gate. The interaction of BOXes with the channel may be further stabilized by the probable ability of hydrophobic and planar BOXes to partition well in membranes and/or to intercalate nonpolar areas of the channel protein, as suggested by the finding that BOXes from either side of the membrane are effective. The relatively hydrophobic characteristic of BOXes should also contribute to the poor reversibility by simple washing. These membranepermeable and light-sensitive characteristics of BOXes somewhat resemble those of the voltage-gated Ca 2 + channel modulators dihydropyridines (Meyer et al, 1984) . The diminished inhibitory effect of the BOXes following sunlight exposure is consistent with an earlier report (Kranc et al, 2000) . Such light exposure has been postulated to photooxidize BOX A and BOX B to MVM (Clark and Sharp, 2006) . Thus, the amide group, present in BOX A and BOX B but absent in MVM ( Figure 1A) , may be required to inhibit the Slo1 BK channel.
In addition to the sequence 329 RKK 331 , there may be other determinants of the inhibitory effect of BOXes because the RKK mutation leaves B35% to 40% of the inhibition intact. Mechanistically, the sequence 329 RKK 331 in the S6-RCK1 linker could function as a binding site component. Alternatively, the RKK mutation may alter the accessibility of BOXes to the binding sites located elsewhere. Our results do not directly distinguish these two possibilities.
The exact structural location of the ion conduction gate in the Slo1 channel is yet to be revealed, and consequently, elucidation of the physicochemical basis of the preferential closed-state stabilization by BOXes requires further investigation. The linker connecting the S6 segment and the cytoplasmic RCK1 domain, which includes the sequence 329 RKK 331 , has been envisioned to work like a passive mechanical spring to influence voltage-dependent gating of the Slo1 channel (Niu et al, 2004) . However, it may be noted that our results do not show that BOXes alter the strongly voltage-dependent transitions mediated by the transmembrane voltage sensors.
Multiple types of K + channels are expressed in vascular smooth muscle cells and alterations in any one of the channels could contribute to vascular dysfunction, including delayed cerebral vasospasm (Wellman, 2006) . A transcript profiling study using a canine model of SAH involving autologous blood injection documented the downregulation of Kv2.2 and upregulation of Kir2.1 but no change in the expression of Slo1 or Cav1.2 (Aihara et al, 2003) . Using the same canine model of SAH, Jahromi et al (2008) showed that the BK channel activity in acutely dissociated basilar artery smooth muscle cells is unaltered; however, the concentrations of BOXes were not measured in the study. How these findings using native cells harvested from the experimental SAH animals relate to our finding that BOXes regulate Slo1 is not clear. It is possible that the inhibitory effect of BOXes was somehow removed during the cell dissociation process, or that native BK channels possess or are exposed to cellular factors that protect them from BOXes or facilitate their unbinding. SAH leads to the generation of multiple hemoglobin breakdown products, the concentrations of which in the CSF change with time. One of the early breakdown products is oxyhemoglobin, which has been suggested to have a role in SAH-induced cerebral vasospasm. The role played by oxyhemoglobin, however, may, some argue, be limited to early vasoconstrictive effects owing to its relatively short time in the hemolysate and also in part to its ability to scavenge the vasodilator nitric oxide (Windmuller et al, 2005) . Thus oxyhemoglobin is an antidilatory agent as opposed to a procontractile agent (Aoki et al, 1994; Windmuller et al, 2005) . The role of oxyhemoglobin in vasoconstriction during delayed vasospasm at 3 to 7 days is therefore unclear compared with other chemical species resulting from the hemorrhage. Bilirubin oxidation end products, in contrast, may serve as a procontractile agent , and the inhibitory effect of BOXes on the Slo1 channel may contribute to the development of delayed cerebral vasospasm following SAH.
